Which subgroup of patients with MAC lung disease, based on radiographic findings and symptoms, are likely to manifest clinical improvement with oral antimicrobial therapy? What role do underlying co-morbid condition play in predicting response?

Which subgroup of patients with MAC lung disease, based on radiographic findings and symptoms, are likely to manifest clinical improvement with oral antimicrobial therapy? What role do underlying co-morbid condition play in predicting response?

Which subgroup of patients with MAC lung disease, based on radiographic findings and symptoms, are likely to manifest clinical improvement with oral antimicrobial therapy? What role do underlying co-morbid condition play in predicting response? 


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Julie Philley, MD

Julie Philley, MD

Chair of the Department of Medicine
Chief of Pulmonary and Critical Care
UT Health North Campus Tyler
The University of Texas Health Sciences Center
Houston, Texas